Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.22.2.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2021
Mar. 31, 2021
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Cash Flows Used in Operating Activities              
Net (loss) income $ (20,330) $ (11,557) $ 14,506 $ (12,539) $ (31,887) $ 1,967  
Adjustment to reconcile net (loss) income to net cash used in operating activities:              
Depreciation and amortization         650 625  
Amortization of intangible assets         3,026 2,007  
Amortization of right of use asset         353 370  
Stock based compensation 700   2,100   2,274 7,149  
Earnout expense valuation benefit         (2,827) 0  
Loss on exchange of debt for equity 0   0   0 30  
Amortization of debt discount         0 224  
Amortization of original issued discount         (92) 0  
Accrued interest income, related party         0 (1,627)  
Unrealized gain on note         344 (490)  
Recovery for valuation allowance for held for sale loan 0   (7,462)   0 (7,345)  
Gain on settlement of related party promissory note and loan related party receivable 0   (49,817)   0 (49,817)  
Deferred income tax         (1) (4,507)  
Unrealized gain/(loss) on equity securities (247)   28,965   1,256 28,965  
Impairment of goodwill 7,570   0   7,570 0  
Other         181 57  
Changes in operating assets and liabilities:              
Accounts receivable and other receivables         361 532  
Inventory         285 (555)  
Prepaid expenses and other current assets         1,357 (319)  
Other assets         25 203  
Accounts payable         (1,498) (331)  
Accrued liabilities         542 2,494  
Income tax liabilities         (40) 6,711  
Deferred revenue         (1,096) (238)  
Operating lease obligation         (327) (364)  
Other liabilities         0 96  
Net Cash Used in Operating Activities         (19,544) (14,163)  
Cash Flows Used in Investing Activities              
Purchase of property and equipment         (140) (149)  
Investment in capitalized software         (306) (373)  
Investments in short term investments         0 (2,000)  
Purchase of convertible note         (5,500) 0  
Purchases of treasury bills         0 (63,362)  
Sales of treasury bills         43,001 28,000  
Purchase of Systat licensing agreement         0 (900)  
Acquisition of Game Your Game         0 184  
Acquisition of CXApp         0 (15,186)  
Acquisition of Visualix         0 (61)  
Net Cash Provided By (Used in) Investing Activities         37,055 (53,847)  
Cash From Financing Activities              
Net proceeds from issuance of preferred stock and warrants         46,906 0  
Net proceeds from issuance of common stock and warrants         0 77,853  
Net proceeds from promissory note         364 0  
Cash paid for redemption of preferred stock series 7         (49,250) 0  
Taxes paid related to net share settlement of restricted stock units         (336) (1,687)  
Loans to related party         0 (117)  
Repayment of CXApp acquisition liability         (1,847) (137)  
Repayment of acquisition liability to Nanotron shareholders         0 (467)  
Repayment of acquisition liability to Locality shareholders         0 (500)  
Net Cash (Used In) Provided By Financing Activities         (4,163) 74,945  
Effect of Foreign Exchange Rate on Changes on Cash         (73) (19)  
Net Increase in Cash and Cash Equivalents         13,275 6,916  
Cash and Cash Equivalents - Beginning of period   $ 52,480   $ 17,996 52,480 17,996 $ 17,996
Cash and Cash Equivalents - End of period $ 65,755   $ 24,912   65,755 24,912 $ 52,480
Cash paid for:              
Interest         2 1  
Income Taxes         100 0  
Non-cash investing and financing activities              
Common shares issued for extinguishment of debt         2,000 1,500  
Common shares issued for CXApp Earnout Payment         3,697 0  
Common shares issued in exchange for warrants         14 0  
Right of use asset obtained in exchange for lease liability         284 0  
Settlement of Sysorex Note         0 7,462  
Investment in equity securities         0 58,905  
Common shares issued for CXApp acquisition         0 10,000  
Common shares issued for Game Your Game acquisition         0 1,403  
Common shares issued for Visualix asset acquisition         $ 0 $ 429